FDA approves the Flexichamber collapsible valved holding chamber

FSC Laboratories has announced that its Flexichamber collapsible valved holding chamber has received FDA clearance for use with most pMDIs. The device, which can be used with or without a mask, will be available by prescription only and will be distributed by FSC Pediatrics.

FSC Pediatrics President and CEO Peter W. Steelman commented, “We developed Flexichamber, a patented, compact collapsible holding chamber, to address pediatric patient and parent needs by combining the clinical effectiveness expected from the leading hard-sided chambers and the convenience of a device that can easily fit in a pocket, backpack, or purse.”

Read the FSC Laboratories press release.

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK